EUVIMED · CrossrefZeitschrift
NAR Cancer
ISSN 2632-8674 · Oxford University Press (OUP)
Neueste Artikel
Environmental epimutagens, epigenetic memory, and cancer latency
DNA repair helicases: from mechanistic understanding to therapeutic implications
Targeting DNA repair mechanisms in cancer therapy: the role of small molecule DNA repair inhibitors
Polymerase θ—what does it see, and why does it matter for cancer therapy?
Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models
What is in a name? Rethinking SMUG1 in genome maintenance
The alternative lengthening of telomeres pathway through a DNA repair lens: mechanism and therapeutic opportunities
SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression
Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP
PARP inhibitor response is enhanced in prostate cancer when XRCC1 expression is reduced
Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach
The IGF2BP1 oncogene is a druggable m6A-dependent enhancer of YAP1-driven gene expression in ovarian cancer
Matrix stiffness modulates androgen response genes and chromatin state in prostate cancer
Expanded detection and impact of BAP1 alterations in cancer
Spatial transcriptomics in breast cancer reveals tumour microenvironment-driven drug responses and clonal therapeutic heterogeneity
Ribosome specialization in cancer: a spotlight on ribosomal proteins
Decoding ribosome complexity: role of ribosomal proteins in cancer and disease
Microsatellite break-induced replication generates highly mutagenized extrachromosomal circular DNAs
Codelivery of TGFβ and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint Inhibitors
Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance
The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest
Detection of oxaliplatin- and cisplatin-DNA lesions requires different global genome repair mechanisms that affect their clinical efficacy
Co-evolution of AR gene copy number and structural complexity in endocrine therapy resistant prostate cancer
Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity
Therapeutic disruption of RAD52–ssDNA complexation via novel drug-like inhibitors
GSK-3484862 targets DNMT1 for degradation in cells
Alterations of ribosomal RNA pseudouridylation in human breast cancer
Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs
Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy
Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment
EUVIMED